"Coalition building - civil society, government - when we work together is when we can really make a difference in #NCDs and heart disease." - ACC Past President Dr. @jgharoldmd on approaching NCDs in a large and diverse country like the US at the #NCDCafe at #ESCCongress pic.twitter.com/F0dobTN614

— ACC Media Center (@ACCmediacenter) September 1, 2019

DAPA-HF "unmistakably demonstrates the role of the SGLT2 inhibitor class of agents for managing risk in patients with #heartfailure," #ACCBOT member @JJHeart_doc tells @theheartorg at #ESCCongress. https://t.co/JKkaq3QObl pic.twitter.com/fNWQpGNMjt

— ACC Media Center (@ACCmediacenter) September 2, 2019

Check out ACC's Visual Abstract of the THEMIS Trial, which found ticagrelor + aspirin was associated with a reduction in CV events, with an increase in major bleeding vs. aspirin. #ESCCongress @usamanasirmd https://t.co/oFccqr81Kg pic.twitter.com/tzOk9f54Ne

— American College of Cardiology (@ACCinTouch) September 1, 2019

ICYMI: ACC leaders addressed the realities of clinician burnout at #ESCCongress.

"The costs – both financially and in terms of patient care – are too big to ignore."

Read more about the #clinicianwellbeing session: https://t.co/uuOv1NhdB9 pic.twitter.com/Z9DCXBV0vu

— American College of Cardiology (@ACCinTouch) September 4, 2019

#JACCCardioOnc Editor Dr. Bonnie Ky and Dr. @CardioOncology discuss the exciting cardio-onc science at #ESCCongress. @rudolf_deboer pic.twitter.com/wW5sCqb3Kh

— JACC Journals (@JACCJournals) September 1, 2019

#ESCCongress #WCC2019 is nearly over! Visit the World Heart Federation and @ACCinTouch booths in the ESC Plaza for a 25% discount to #ACC20/#WCCardio in Chicago next year! pic.twitter.com/wDi2iPtGBx

— WorldHeartFederation (@worldheartfed) September 3, 2019

American College of Cardiology Assembly of International Governors @ACCinTouch @JACCJournals @jgharoldmd @DickKovacs A world where innovation and knowledge optimize cardiovascular care and outcomes - 42 International Chapters - International Strategy - A Global Force for #NCDs pic.twitter.com/n0qDqQjCJO

— JOHN GORDON HAROLD, MD, MACC, MACP, FRCP, FRCPI (@jgharoldmd) September 1, 2019

At #ESCCongress? Stop by ACC Stand # G02 in the ESC Plaza to meet @JGrapsa and learn more about the new #JACCCaseReports. https://t.co/geadQ5SpFg pic.twitter.com/lAdpQzgkdN

— American College of Cardiology (@ACCinTouch) September 1, 2019

ACC President Dr. @DickKovacs tells @medpagetoday he doesn't think THEMIS will change practice: https://t.co/kSQiO3qZ1Q #ESCCongress pic.twitter.com/D9akaA5Rv3

— ACC Media Center (@ACCmediacenter) September 2, 2019

New COMPASS data found rivaroxaban plus aspirin vs. aspirin alone produced similar benefits and similar risks of bleeding in women & men. Learn more in this trial update. #ESCCongress https://t.co/ujU3urTSp8

— American College of Cardiology (@ACCinTouch) August 31, 2019